Cargando…

Using Patient-Level Data to Develop Meaningful Cross-Trial Comparisons of Visual Impairment in Individuals with Diabetic Macular Edema

INTRODUCTION: The aim of this study was to assess the impact of baseline characteristics on visual outcome of patients with diabetic macular edema and compare the results of clinical trials with different patient populations. METHODS: A model was created with patient-level data from the RESPOND/REST...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sivaprasad, Sobha, Regnier, Stephane A., Fajnkuchen, Franck, Wright, Jonathan, Berger, Alan R., Mitchell, Paul, Larsen, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846684/ https://www.ncbi.nlm.nih.gov/pubmed/26951552 http://dx.doi.org/10.1007/s12325-016-0310-0

Ejemplares similares

Impact of treatment of diabetic macular edema on visual impairment in people with diabetes mellitus in India
por: Kulkarni, Sucheta, et al.
Publicado: (2021)

Efficacy of Anti-VEGF and Laser Photocoagulation in the Treatment of Visual Impairment due to Diabetic Macular Edema: A Systematic Review and Network Meta-Analysis
por: Régnier, Stephane, et al.
Publicado: (2014)

Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema
por: Sarda, Valérie, et al.
Publicado: (2020)

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
por: Sivaprasad, Sobha, et al.
Publicado: (2016)

Factors Affecting Reading Speed in Patients with Diabetic Macular Edema Treated with Laser Photocoagulation
por: Pearce, Elizabeth, et al.
Publicado: (2014)

Indicators of Visual Prognosis in Diabetic Macular Oedema
por: Sen, Sagnik, et al.
Publicado: (2021)

Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective
por: Régnier, Stephane A, et al.
Publicado: (2015)

Sensitivity and specificity of time-domain versus spectral-domain optical coherence tomography in diabetic macular edema
por: Patel, Nishal, et al.
Publicado: (2013)

Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema
por: Ramu, Jayashree, et al.
Publicado: (2017)

An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema
por: Sivaprasad, Sobha, et al.
Publicado: (2014)

Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant
por: Herbaut, Antoine, et al.
Publicado: (2017)

Visual and Anatomical Outcomes of a Single Intravitreal Dexamethasone in Diabetic Macular Edema: An 8 Year Real-World Study
por: Faes, Livia, et al.
Publicado: (2023)

Mapping From Visual Acuity to EQ-5D, EQ-5D With Vision Bolt-On, and VFQ-UI in Patients With Macular Edema in the LEAVO Trial
por: Pennington, Becky M., et al.
Publicado: (2020)

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials
por: Dugel, Pravin U, et al.
Publicado: (2016)

Predictors of Visual Acuity Outcomes after Anti–Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion
por: Sen, Piyali, et al.
Publicado: (2021)

Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
por: Sivaprasad, Sobha
Publicado: (2008)

Visual outcome of ranibizumab therapy for neovascular age related macular degeneration in the black population: a report of five cases
por: Vemala, Roopa, et al.
Publicado: (2010)

Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial
por: Garweg, Justus G., et al.
Publicado: (2022)

Treatment Efficacy and Compliance in Patients with Diabetic Macular Edema Treated with Ranibizumab in a Real-Life Setting
por: Best, Anne-Laurence, et al.
Publicado: (2018)

Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema
por: Bandello, Francesco, et al.
Publicado: (2011)

Appropriateness of quality standards for meaningful intercentre comparisons of aflibercept service provision for neovascular age-related macular degeneration
por: Talks, J S, et al.
Publicado: (2017)

Living Without a Diagnosis: A Patient’s Perspective on Diabetic Macular Ischemia
por: Humphreys, Jacqueline D., et al.
Publicado: (2022)

Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
por: Sivaprasad, Sobha, et al.
Publicado: (2008)

Estimating the costs of blindness and moderate to severe visual impairment among people with diabetes in India
por: Redding, Stuart, et al.
Publicado: (2023)

Quantitative effect of subretinal fluid and intraretinal edema on visual acuity in uveitic cystoid macular edema
por: Weldy, Eric W., et al.
Publicado: (2021)

Scotopic thresholds on dark-adapted chromatic perimetry in healthy aging and age-related macular degeneration
por: Grewal, Manjot Kaur, et al.
Publicado: (2021)

Key drivers of visual acuity gains in neovascular age-related macular degeneration in real life: findings from the AURA study
por: Holz, Frank G, et al.
Publicado: (2016)

Visual Acuity Gain Profiles and Anatomical Prognosis Factors in Patients with Drug-Naive Diabetic Macular Edema Treated with Dexamethasone Implant: The NAVEDEX Study
por: Pinto, Mauricio, et al.
Publicado: (2021)

An exploratory study evaluating the effects of macular carotenoid supplementation in various retinal diseases
por: Crosby-Nwaobi, Roxanne, et al.
Publicado: (2016)

Commentary: Impact of treatment of diabetic macular edema on visual impairment in people with diabetes mellitus in India
por: Mishra, Chitaranjan
Publicado: (2021)

Diabetic macular edema treatment guidelines in India: All India Ophthalmological Society Diabetic Retinopathy Task Force and Vitreoretinal Society of India consensus statement
por: Giridhar, Sneha, et al.
Publicado: (2021)

Normative spectral domain optical coherence tomography data on macular and retinal nerve fiber layer thickness in Indians
por: Appukuttan, Bindu, et al.
Publicado: (2014)

Quantitative Autofluorescence in Non-Neovascular Age Related Macular Degeneration
por: Chandra, Shruti, et al.
Publicado: (2023)

Exploratory Study on Visual Acuity and Patient-Perceived Visual Function in Patients with Subretinal Drusenoid Deposits
por: Grewal, Manjot K., et al.
Publicado: (2020)

When is macular edema not macular edema? An update on macular telangiectasia type 2
por: Wu, Lihteh
Publicado: (2015)

Watching synchronous mitochondrial respiration in the retina and its instability in a mouse model of macular degeneration
por: Kaynezhad, Pardis, et al.
Publicado: (2021)

Correlation of Optical Coherence Tomography Angiography Characteristics with Visual Function to Define Vision-Threatening Diabetic Macular Ischemia
por: Tsai, Wei-Shan, et al.
Publicado: (2022)

Effect of macular photocoagulation on visual acuity of Omani patients with clinically significant macular edema
por: Zaidi, Zafar A., et al.
Publicado: (2009)

Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema
por: Abdel-Hay, Ahmed, et al.
Publicado: (2018)

Clinically meaningful visual improvements and predictors of early vision gains with ranibizumab for diabetic macular oedema
por: Morse, Lawrence, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0bb2hg42pvjd86ocl6d9hqhmvj